Tamarack Advisers, LP Viatris Inc Transaction History

Tamarack Advisers, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$9.59 - $11.35 $5.51 Million - $6.53 Million	-575,000 Reduced 46.0%	675,000 $6.66 Million
Q2 2023 Aug 09, 2023	SELL	$9.02 - $10.29 $2.26 Million - $2.57 Million	-250,000 Reduced 16.67%	1,250,000 $12.5 Million
Q1 2023 May 10, 2023	BUY	$9.2 - $12.26 $4.83 Million - $6.44 Million	525,000 Added 53.85%	1,500,000 $14.4 Million
Q4 2022 Feb 10, 2023	BUY	$8.72 - $11.56 $2.83 Million - $3.76 Million	325,000 Added 50.0%	975,000 $10.9 Million
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $2.54 Million - $3.34 Million	300,000 Added 85.71%	650,000 $5.54 Million
Q2 2022 Aug 16, 2022	BUY	$9.95 - $12.27 $1.24 Million - $1.53 Million	125,000 Added 55.56%	350,000 $3.67 Million
Q1 2022 May 11, 2022	SELL	$9.81 - $15.4 $2.7 Million - $4.24 Million	-275,000 Reduced 55.0%	225,000 $2.45 Million
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $3.93 Million - $4.77 Million	-325,000 Reduced 39.39%	500,000 $6.77 Million
Q2 2021 Aug 13, 2021	BUY	$12.97 - $16.15 $7.46 Million - $9.29 Million	575,000 Added 230.0%	825,000 $11.8 Million
Q1 2021 May 12, 2021	SELL	$13.59 - $18.54 $2.72 Million - $3.71 Million	-200,000 Reduced 44.44%	250,000 $3.49 Million
Q4 2020 Feb 10, 2021	BUY	$14.3 - $18.74 $6.44 Million - $8.43 Million	450,000 New	450,000 $8.38 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Tamarack Advisers, LP with notifications on news.